The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy

Año publicación: 2024

Subir documento: https://www.nature.com/articles/s41598-024-75965-2

Nombre investigadores: Edy Kornelius, Jing-Yang Huang, Shih-Chang Lo, Chien-Ning Huang, Yi-Sun Yang